Table 4.

The univariate analysis of OS and PFS.

Variable	N	OS Median (months)	P	PFS Median (months)	P
Gender
Male	18	12.8	0.490	6.9	0.993
Female	9	9.1		7.6
Age
≤60	14	10.2	0.413	6.9	0.570
>60	13	11.3		7.1
ECOG
0–1	15	12.3	0.008	9.1	0.019
2	9	11.3		7.1
3	3	2.9		1.9
N stage
N0	12	15.3	0.021	11.9	0.131
N+	15	8.9		6.6
Follow-up chemotherapy
No	9	5.3	<0.001	3.6	<0.001
Yes	18	13.4		10.8
Degree of decline of CA199
<50%	11	6.4	0.002	3.6	0.002
≥50%	16	11.6		9.8
BED10
≥60	16	12.8	0.834	7.4	0.637
<60	11	7.5		6.1
NRS
≤3	10	11.6	0.319	7.35	0.480
≥4	17	9.1		6.1
SII
≥821.9	8	9.4	0.017	4.8	0.017
<821.9	19	11.3		9.1
NLR
≥1.26	19	11.3	0.045	7.1	0.045
<1.26	8	9.05		8.7
PLR
≥105.2	21	8.9	0.052	6.1	0.107
<105.2	6	20.8		15.8
PNI
≥49.88	8	12.7	0.019	11.1	0.019
<49.88	19	7.5		6.1
FFLP
≥10	14	15.6	0.001	12.8	0.001
<10	13	6.1		4.1